| Financial Year |
March 31 2023 |
| Monetary Funds |
400,361,690.38 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
14,757,187.31 |
| Accounts Receivable |
88,634,569.43 |
| Advances to Suppliers |
4,088,911.89 |
| Other Receivables |
3,555,132.84 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
197,786,949.59 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
17,022,785.78 |
| Total Current Assets |
760,899,718.38 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
530,579,660.08 |
| Under-construction Projects |
72,064,037.73 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
52,729,669.64 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
32,796.99 |
| Deferred Income Tax Assets |
28,740,662.04 |
| Other Non-Current Assets |
8,428,982.36 |
| Sub-Total of Non-Current Assets |
694,674,325.51 |
| Total Assets |
1,455,574,043.89 |
| Short-Term Loans |
51,066,666.66 |
| Trading Financial liabilities |
-- |
| Notes Payable |
95,514,668.76 |
| Accounts Payable |
121,804,529.67 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
8,377,039.57 |
| Taxes Payable |
7,355,293.56 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
34,401,968.40 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
11,700,632.44 |
| Other Current Liabilities |
1,577,228.99 |
| Sub-Total of Current Liabilities |
332,697,238.36 |
| Long-term Loans |
235,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
884,195.35 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
263,319,040.41 |
| Total Liabilities |
596,016,278.77 |
| Paid-In Capital(Or Share Stock) |
101,017,880.00 |
| Capital Surplus |
387,704,631.86 |
| Surplus Reserve |
34,511,162.87 |
| LESS:Treasury Stock |
26,931,210.80 |
| Undistributed Profits |
239,911,417.17 |
| Minority Stockholder's Interest |
123,343,884.02 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
736,213,881.10 |
| Owner's Equity（Stockholder's Equity） |
859,557,765.12 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,455,574,043.89 |
